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Summary Clinico-pathological features of prognostic significance in rectal cancer are described in 824 patients who were treated at 17 centres in the Medical Research Council Trial of radiotherapy in operable
cancer of the rectum. Among the pre-operative assessments the mobility of the tumour was the one most
strongly related to prognosis. Other variables predictive of outcome were the number of involved quadrants
of the rectum, the distance of the tumour from the anal verge and the age of the patient. Of assessments
made at surgery or immediately after, the report of a curative operation and the Dukes' classification most
closely related to prognosis. The information presented supports the idea that a pre-operative clinical staging
system for rectal cancer would be feasible and useful.
Following the studies of the Veterans' Association
in the United States (Roswit et al., 1975) and the
Princess Margaret Hospital in Toronto, Canada
(Rider et al., 1977), the Medical Research Council
of the United Kingdom began in 1975 a trial of
pre-operative radiotherapy in patients with operable
rectal cancer. The design and the protocol of the
trial are described in the first report (First MRC
Report, 1982). The patients were treated in 17
different regions throughout the UK by surgeons
and radiation oncologists who agreed to participate
in the study. In a period of just over three years,
between March 1975 and August 1978, 824 patients
with rectal cancer were recruited to the study. They
were then randomly allocated to immediate
definitive surgery or to pre-operative adjuvant
radiotherapy of either 500cGy in a single exposure,
or 2000cGy in 10 fractions over two weeks. Since
there was no difference between the control and
irradiation treatment group as to surgical outcome
(Second MRC Report, 1984), the whole group can
be used to determine the validity of factors in the
pre-operative assessment and histology in
determining prognosis. This paper identifies a
number of clinico-pathological features important
in this respect.
Pre-treatment assessment
Patients were entered into the trial to around 80
years of age if they had an operable tumour which
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was histologically confirmed as an adenocarcinoma
which had its lower margin < 15cm from the anal
verge. Since the mean tumour diameter was 5 cm
the selection of patients with tumours confined to
15cm allowed tumours of the rectum proper (i.e.
up to 17-18cm from the anal verge) to be included
but effectively excluded tumours at the recto-
sigmoid junction and above. The mean follow-up
period for these patients is now 5 years, and only
6% (51 patients) have been followed for <4 years.
Age and sex
There were 824 patients, of whom 516 (63%) were
male. The age distribution of patients is given in
Figure 1. The youngest patient was 32 years old
and the eldest 86, with an average age of 64.5
years.
Height
Sigmoidoscopy was carried out in 800 (97%) of the
patients and the height ofthe tumour above the anal
verge was measured. In 501 (61%) patients the
lower margin of the tumour was within 8 cm of the
anal verge, the remainder having lesions from 9-
15cm.
Mobility
Pre-treatment assessment by digital examination
and sigmoidoscopy revealed that 401 (49%)
tumours were mobile and that 364 (44%) were
"tethered" in the pelvis. Examination under
anaethesia assisted in determining fixity in a few
instances but was not a requirement of the trial.
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Figure 1 Distribution of age at entry to trial of 824
patients.
Forty-three percent of the tethered tumours were
later considered to be completely fixed. For 59
(7%) patients no assessment was recorded.
Quadrants involved
The number of quadrants of the rectum involved
was recorded at sigmoidoscopy in 793 (96%)
patients. The distribution of involved quadrants is
given in Figure 2. In almost half the patients only
one quadrant of the rectum was involved with
tumour. Of patients with mobile tumours, the
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Figure 2 Number of quadrants of the rectum
involved related to the mobility of the tumour in 824
patients.
proportion with only one quadrant of the rectum
involved was 59%, which was significantly greater
than the proportion in the group with tethered
tumours (41%) (X2=25.5 on 1 df, P<0.001).
It was noted that mobile tumours occurred more
frequently in the higher rectum. One hundred and
forty-seven (37%) of mobile cancers had their lower
limit >8cm from the anal verge compared with 106
(30%) of tethered tumours (X2=4.86 on 1 df,
P<0.03).
Operative procedures
It was found that 739 (90%) patients considered
eligible for the trial were suitable for radical surgery
at the time of laparotomy. Abdomino-perineal
excision was the most common definitive operation
and was performed in 564 (68%) patients. Anterior
restorative resection was performed in only 175
(21%). It will be noted that 85 (10%) patients were
found at the time of operation to be unsuitable for
definitive resection. Thus the surgeon's initial
assessment of operability turned out to be correct
in 90% of the patients.
Abdomino-perineal excision of the rectum was
performed in 364 males and 200 females. Excision
of the posterior vaginal wall was carried out in 76
(38%) of these female patients. It was noted that
excision of the posterior vaginal wall was carried
out more frequently (49%) when the cancer
involved the anterior quadrant of the rectum, as it
did in 108 female patients, than when the anterior
quadrant was not involved (24%) (x2= 11.7 on 1 df,
P<0.001). Excision of the posterior vaginal wall
was performed in 26% when the lower limit of the
cancer was >8 cm from the anal verge compared to
41% when lower lying lesions were resected. This
difference is not statistically significant (X2 =2.71 on
1 df, P=0.10) but there is a consistent trend when
the height of the tumour is subdivided into smaller
intervals.
Anterior restorative operations were performed in
175 (21%) patients who were suitable for definitive
surgery and more commonly in patients with
tumours lying 11 cm or more from the anal verge
than in the middle or lower rectum. In this series
96/143 patients (67%) with cancers 11-15cm above
the anal verge were managed by anterior restorative
resection. This percentage may be compared with
77/657 patients (12%) with lower lying tumours
which were removed by anterior restorative
resection. It was also found that anterior restorative
operations were performed significantly more
frequently in females (27%) than in males (18%)
2=8.53on 1df,P=0.004).
Radical surgery was carried out in 739 patients
(90%) admitted to the trial. The feature which
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related most strongly to operability was mobility of
the tumour. Ninty-five percent of patients with
mobile tumours were resectable compared to only
68% of those with fixed cancers.
A curative resection was defined as having been
performed when a surgeon considered that the local
excision of the cancer had been complete and that
there was no evidence of intra-abdominal spread of
the disease. Only 69% of the resectable group were
considered to have had a curative resection. The
proportion of patients considered to have a curative
operation was similar after both abdomino-perineal
excision (68%) and anterior restorative resection
(73%) (X2=0.85 on 1 df, P=0.36).
Mobility of the tumour was again the feature
which related most strongly to the surgeon's
assessment of the resectability. Of the 739 patients
who had radical surgery the proportion considered
to have had a curative resection was 83% for those
with a mobile tumour, 54% for those to be
partially fixed and 42% for those with fixed cancers
in the rectum.
Pathological examination of the resected specimen
The resected rectum was examined and reported in
a standard manner in 741 (90%) patients in the
series. Most of the other 10% represented the
patients who did not have a radical resection, that
is neither an abdomino-perineal excision nor an
anterior restorative operation was performed.
The distribution of Dukes' staging is shown in
Figure 3. The percentage of A cases is higher than
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Figure 3 Distribution of patients by Dukes' Stage.
that classically recorded by Dukes (1940) and later
stated to be unchanged by Nicholls (1982). It
has therefore to be considered whether this could
be an effect of radiotherapy, but in the first report
of the trial, however, the percentage of A cases was
identical in the control and irradiated groups (First
MRC report, 1982). The resected tumours were also
graded histologically. Sixty seven percent were
classified as average grade, 16% as low grade and
the remaining 15% were considered to be high
grade or anaplastic tumours with 2% not graded.
The correlation between Dukes' stage and
histological grade is shown in Table I. The tumours
of low grade have the highest proportion of Dukes'
A stage, whereas the tumours of high grade have
the highest proportion of Dukes' C stage (X2=32.3
on 4df, P<0.001).
The Dukes' stage was also seen to be related to
the maximum diameter of the cancer in the rectum
(x2= 12.55 on 2df, P=0.006) (Table II). The
proportion of patients with cancers greater than
5cms in diameter was 44% for tumours of Dukes'
stage A, 59% in Dukes' B and 53% in Dukes' C.
This suggests that large size may influence the local
invasion of the tumour more than it does the
lymph node metastases. The Dukes' staging was
also correlated to the fixity of the tumour in the
pelvis. The proportion of Dukes' stages A, B and C
for mobile, partially fixed and fixed cancers is given
in Table III. It can be seen that there is a smaller
proportion of Dukes' Stage A cancers and a larger
proportion of Dukes' B for tethered tumours
whereas the proportion of Dukes' Stage C lesions
differs little between mobile and tethered tumours
(2 = 19.8 on 4df, P<0.001).
Factors in prognosis
It is possible to relate a number of features, which
were determined at pre-treatment assessment,
operation or pathological examination of the
tumour, with local disease-free rates and disease-
free survival. In this section tables are presented for
factors of possible prognostic importance. Each
table gives information on the curative resection
rate, the local disease-free rate, the survival rate
and the disease-free survival rate. Curative resection
has been defined above. The local disease-free rate
is calculated as the acturial proportion of patients
clinically free of disease in the pelvis. The survival
rate and the disease-free survival rates have also
been calculated by the actuarial method. The total
number of deaths which have occurred during the
study is 504, of which 100 are not clearly ascribable
to cancer of the rectum. Thirty-five of these
occurred within 3, months of entry to the trial and
were probably related to the operation. Most of the438 W. DUNCAN et al.
Table I Dukes' stage related to histological grade
Dukes' stage
Histological Not
grade A B C known Total
Low 43 (25) 34 (13) 44 (14) 1 122 (16)
Average 113 (67) 187 (72) 194 (62) 0 494 (67)
High 10 (6) 33 (13) 67 (22) 1 111 (15)
Not known 3 (2) 5 (2) 5 (2) 1 14 (2)
Total 169 (100) 259 (100) 310 (100) 3 741 (100)
Table II Dukes' stage related to size of tumour
Dukes' stage
Maximum diameter Not
oftumour A B C known Total
<5cm 89 (53) 88 (34) 130 (42) 1 308 (42)
_5cm 75 (44) 153 (59) 163 (53) 0 391 (53)
Not known 5 (3) 18 (7) 17 (5) 2 42 (5)
Total 169 (100) 259 (100) 310 (100) 3 741 (100)
Table III Dukes' stage related to fixity of tumour
Fixity
Partially Completely Not
Dukes' stage Mobile fixed fixed known Total
A 108 (28) 37 (16) 12 (15) 12 169 (23)
B 110 (29) 90 (39) 36 (45) 23 259 (35)
C 160 (42) 103 (45) 32 (40) 15 310 (42)
Not known 3 (1) 0 (-) 0 (-) 0 3 (-)
Total 381 (100) 230 (100) 80 (100) 50 741 (100)
remainder were recorded as being due to diseases of
old age. However, all deaths regardless of cause
have been included in the calculation of the survival
rates, this being considered to provide the most
objective assessment. The tables give rates at 5
years. The statistical tests are based on the
difference between the rates divided by the standard
error of the difference as calculated by
Greenwood's (1926) method.
Age and sex
Disease-free and survival rates of patients by age
are given in Table IV. It will be seen that patients
over the age of 70 have a significantly poorer
survival than the younger age groups but Table IV
shows that the disease itself is not responsible for
the greater attrition as the disease-free interval is
the same in all age groups. Males and females have
similar overall disease-free survival rates.
Height
Patients with tumours <8 cm from the anal verge
have a significantly poorer prognosis than those
with higher tumours (Table V). Of 501 patients
with tumours lying <8 cm from the anal verge,
35% were alive at 5-years, compared to 48% of the
299 patients with a cancer lying between 8 and
15cm. There was, however, no significant difference
in the proportion of patients having curative
resections, being 62% for patients with low-lying
lesions (<8cm from the anal verge) compared to
65% in patients with cancer in the upper rectum or
recto-sigmoid. The 5-year local disease-free rate is
different for lesions above and below 8cms from
the anal verge, being 62% and 52% respectively.
Similarly, the disease-free survival rate at 5-years is
considerably better (40%) for patients with higher
level cancers than the 29% rate in those with
lesions within 8cms of the anal verge (Table V).PROGNOSTIC FACTORS IN RECTAL CANCER 439
Table IV Age related to prognosis
Age (yrs)
<60 60-69 >70
(n=252) (n=300) (n=270) x P
Curative resection rate (%(s.e.)) 66 (3) 62 (3) 61 (3) 1.33 0.52
Local disease-free rate (%(s.e.)) 5yr 56 (3) 58 (3) 51 (3) 2.44 0.30
Survival rate (%(s.e.))a Syr 45 (3) 44 (3) 31 (3) 14.1 <0.001
Disease-free survival rate (%(s.e.)) 5yr 37 (3) 35 (3) 27 (3) 7.85 0.02
aactuarial figures: not age corrected
Table V Height of tumour related to prognosis
Height oftumour
.8cm >8cm 2
(n=501) (n=299) X P
Curative resection rate (%(s.e.)) 62 (2) 65 (3) 0.35 0.5
Local disease-free rate (%(s.e.)) 5yr 52 (2) 62 (3) 6.87 0.008
Survival rate (%(s.e.)) 5yr 35 (2) 48 (3) 12.9 <0.001
Disease-free survival rate (%(s.e.)) 5yr 29 (2) 40 (3) 10.1 0.001
Mobility
The mobility of the cancer was seen to be of great
prognostic importance. In 401 patients with mobile
lesions 80% were considered to have had curative
resections compared with only 44% of 364 patients
who had tethered lesions. The 5-year local disease-
free rate was greater in patients with mobile lesions
(70%) compared to those with tethered cancers
(37%). No great difference in prognosis was seen
between patients with partially fixed and those with
completely fixed tumours. For example, (Table VI)
the 5-year survival rates were 30% and 25%
respectively (X2=0.74 on ldf, P=0.39). However,
the 5-year survival rate for the 401 mobile tumours
was 48% compared with 29% for the 364 tethered
tumours (Table VI) (X2=29.1 on 1 df, P<0.001),
and Figure 4.
Quadrants involved
Three hundred and ninty-four patients (48% of the
total) were assessed as having only one quadrant
involved. The prognosis is significantly better if one
quadrant is involved. Curative resection was carried
out significantly more often than when .2
quadrants were involved; 72% of the 394 patients
with one quadrant involved had a curative resection
compared with 55% of 399 patients with .2
quadrants involved. Quadrant involvement similarly
influenced the disease-free rate, the survival rate
and disease-free survival rate (Table VII). No
information on the number of quadrants involved
was available for 30 patients; their 5-year survival
rate was 36%.
Type ofoperation
The type of operation performed appears to have
comparatively little relationship to the prognosis in
this series. The proportion of patients undergoing
curative resection is similar (68% and 73%) after
both types of operation, (X2= 1.6 on 1 df, P=0.21).
There is also no significant difference in the local
disease-free rates at 5 years (59% and 66%)
(X2=2.0 on 1 df, P=0.16). There is however an
indication that the 5-year survival rate (41% and
55%) (X2=6.2 on 1 df, P=0.01) and the disease-free
survival rate (34% and 44%) (X2-=.l on 1 df,
P=0.02) may be better in patients who were
managed by anterior restorative resection.
Curative resection
Curative resection as earlier defined was found to
be an extremely important factor in prognosis. In
519 patients who were considered to have
undergone curative resection, the five year survival
rate was 56% compared to only 13% of 304
patients who had residual disease at the time of
operation (X2=209.7 on ldf, P<0.001). It has
already been noted above that the mobility of the
tumours significantly affects the number of curative
sections performed.W_ss~~~~~~~~~~~~~~~o
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Figure 4 Mobility of tumour related to disease-free survival.
Table VI Mobility of tumour related to prognosis
Fixity oftumour
Mobile Tethered 2
(n=401) (n=364) X
Curative resection rate (%(s.e.)) 80 (2) 44 (3) 117.1 <0.001
Local disease-free rate (%(s.e.)) 5 yr 70 (2) 37 (3) 80.5 <0.001
Survival rate (%(s.e.)) 5yr 48 (3) 29 (2) 29.1 <0.001
Disease-free survival rate (%(s.e.)) 5 yr 41 (3) 23 (2) 27.1 <0.001
Table VII Number of quadrants involved related to prognosis
Number ofquadrants involved
1 2-4 2
(n=394) (n=399) x
Curative resection rate (%(s.e.)) 72 (2) 55 (2) 27.8 <0.001
Local disease-free rate (%(s.e.)) 5 yr 64 (3) 48 (3) 18.7 <0.001
Survival rate (%(s.e.)) 5 yr 47 (3) 33 (2) 16.7 <0.001
Disease-free survival rate (%(s.e.)) 5yr 41 (3) 26 (2) 19.0 <0.001
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Dukes' stage
The probability of performing a "curative"
resection was correlated with the Dukes' stage 91%
of Dukes' A, 66% of Dukes' B and 58% of Dukes'
C had a curative resection (X2= 100.0 on 2df,
P<0.001). The local disease-free rate is also related
to Dukes' staging, being 82% at 5 years for
patients with Dukes' Stage A, 63% for Stage B
tumours and 42% for those with Stage C tumours
(x2=77.9 on 2df, P<0.001). This parallels the
highly significant differences in the survival (70%,
47% and 25%) (X2=108.8 on 2df, P<0.001) and
the disease-free survival rates (65%Z, 37% and 20%)
(x2= 107.5 on 2df, P<0.001) of patients at 5-years
in the Dukes' Stages A, B and C.
Histological grade
The histological grade of the cancer was recorded
in 727 (98%) of 741 patients who had their
operative specimen examined. There is an
important difference in the 5-year local disease-free
rate which is 69% for patients with low grade
tumours, 62% for average grade and only 42% in
the group of 111 patients with high grade lesions
(X2 = 17.1 on 2df, P<0.001). The patients with low
grade tumours had a 55% five year survival rate,
whereas 45% of the patients with an average
histological grading survived 5 years, as did 25% of
the patients with high grade cancers (X2=25.2 on
2df, P<0.001). The disease-free survival is also
strongly related to the histological grade of the
tumour. A greater proportion of patients (51%)
with low grade tumours than patients with average
(36%) or high grade lesions (21%) were alive and
free of disease at 5 years (X2 =26.8 on 2df,
P<0.001).
Discussion
The clinico-pathological features described in this
paper have been extracted from the data of 824
patients recruited to the First MRC Trial of Pre-
operative Radiotherapy in Operable Rectal Cancer
(1982), who were treated in 17 centres in the United
Kingdom.
In making the comparisons recorded in this
paper it should be remembered not only that two-
thirds of the patients had been given radiotherapy,
but that the group of patients treated in this way
had similar outcomes, curative resection rates, local
disease-free rates and survival rates to the control
group (Second MRC report, 1984). The protocol of
this trial was designed specifically to recruit patients
with operable cancers of the rectum and this may
explain why the percentage of Dukes' A cases is
higher than in other reported series. Yet only 49%
of patients had completely mobile tumours on pre-
treatment assessment. Another 30% of patients
were reckoned to have partially fixed cancers also
considered suitable for radical surgery and 15% of
patients had fixed cancers at pre-treatment
assessment, but were still considered operable. It is
important to note that two-thirds of the patients
with tethered tumours received radical surgery.
Patients eligible for admission to this trial had an
operable adenocarcinoma of the rectum with lower
margin within 15cm from the anal verge. Since the
mean diameter of the tumours was 4.7cm this
corresponds approximately to tumours whose
centre is up to 17-18 cm from the anal verge. The
majority of patients (68%) were managed by
abdomino-perineal excision and only 21% of
patients were considered suitable for anterior
restorative resection. This reflects the fact that the
trial began in 1975 and therefore antedated the
stapling era in which lower resection and
anastomosis have become more feasible for the
general surgeon. It must also be considered whether
surgeons refrained from anastomosing bowel in
radiation-treated patients because of the risk of
fistula. In the first report of the MRC trial of
radiotherapy in operable cancer of the rectum the
incidence of fistula was higher in the control group
than in the irradiated patients. The survival rates
for anterior restorative resection are usually
reported to be better than those following
abdomino-perineal excision of the rectum (Mayo et
al., 1958; Deddish & Stearns 1961; Lockhart-
Mummery et al., 1976) as was demonstrated,
though not very significantly, in this trial. The
relationship to prognosis of the operation
performed may have been reduced because of the
large numbers of surgeons involved in the trial. The
entry criteria to the trial were however restricted to
patients with rectal cancer only. If those patients
thought to have a better prognosis and suitable for
a sphincter-conserving operation in the upper
rectum, i.e. tumours of the rectosigmoid and
sigmoid, were added the advantage to the group
receiving anterior restorative operation might have
been further magnified. It should not, however be
concluded that the operation is responsible for the
improved prognosis, since tumours higher in the
rectum may from their natural history be less
lethal. Relating to this it was found that tumours
were assessed to be mobile more frequently in the
upper part of the rectum.
The operability rate in the series was 90% and of
these 69% were considered to have had a curative
resection, figures which are consistent with other
published series (Lockhart-Mummery et al., 1976).
The surgeons' assessment in this series that a
curative resection had been performed agreed
closely with the long-term prognosis.442 W. DUNCAN et al.
The overall survival and disease-free survival
rates were found to be strongly related to features
determined at pre-treatment assessment; the single
most important of which was the mobility of the
primary cancer. Fixity of the tumour significantly
reduced the probability of achieving a curative
resection. This was subsequently reflected in a
poorer disease-free survival in this group compared
with patients who had mobile tumours. Evidence of
local extension in relation to fixity, more than one
quadrant involved and Dukes' Stage C generally
indicated a poor prognosis as had been emphasised
in other reports (Wood et al., 1981).
Yet a Dukes' C case could be either fixed or
mobile, while the corollary was established that
small tumours, less invasive through the wall, could
readily have lymph node metastases. It is therefore
not surprising that many mobile tumours turned
out to be Dukes' C stage. More surprising are the
12 instances of clinically fixed tumours which were
reported as Dukes' A stage (Table III). One has to
conclude that mobility may not always be
accurately assessed by the surgeon for a number of
reasons, among which may be included a wrong
clinical appraisal but also surrounding
inflammatory reaction. Nevertheless, despite the
accepted margin of error in this assessment, it
remains an important pre-operative prognostic
factor (Figure 4).
Patients over the age of 70 years had a worse
prognosis than younger patients. It was also found
that patients with cancer arising >8cm from the
anal verge had a better disease-free survival rate
than patients with lower lying cancers, although the
curative resection rates were similar. Patients with
only one quadrant of the rectum involved had a
higher rate of curative resections and a higher
disease-free survival rate than those with more
extensive cancers. In view of the importance of
these factors, all of which may be assessed pre-
operatively, it would now seem possible to devise a
method of clinical prognostic staging for patients
with rectal cancer. Zorzitto et al. (1982) have
suggested one such system. They do not include all
the factors which we have found to relate to
prognosis although their results agree with ours in
that mobility of the tumour is found to be an
assessment of primary importance. A clinical
staging system would be useful in delineating those
patients for whom adjuvant therapy might be
considered, particularly if the adjuvant therapy
were to be given pre-operatively. Dukes' staging,
the histological grade of the cancer (Mayo et al.,
1958) and the surgeons' assessment of a curative
operation were all very strongly related to the
prognosis, as is well documented in the literature
but can only be used post-surgery. The analysis
presented here has identified factors which
individually relate to prognosis. Many of these
factors are inter-related and the independent effects
of each factor on prognosis need to be
disentangled. Multivariate analysis of the data may
help to achieve this and if so should form the basis
of sound clinical and clinico-pathological staging
systems for rectal cancer.
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